Arquer Diagnostics: New head for Dx

Diagnostics company Arquer Diagnostics Ltd (Sunderland, UK) has appointed Nadia Whittley as CEO, replacing Ian Campbell with immediate effect. Whittley will be responsible for launching the company’s MCM5-ELISA diagnostic test and the expanding the technology beyond bladder and prostate cancer. 
Read more

Novo Nordisk: Passing the baton

Lars Fruergaard Jørgensen, currently executive vice president and head of Corporate Development at Novo Nordisk, will take over the helm of the Danish diabetes major. He takes over from long-time CEO Lars Rebien Sørensen.

Read more

Acesion Pharma: New head of finance

Danish biotech Acesion Pharma has hired Jakob Dynnes Hansen as its Chief Financial Officer. He joins from Evolva, a Swiss biotech company, where he has been CFO since 2007.
Read more

PharmaMar: Pushing the borders

PharmaMar is driving the expansion of its US operations. To this end, the company has appointed Pascal Besman to the newly created role of Chief Operation Officer of the marine-derived oncology drug developers US subsidiary, PharmaMar US. 
Read more

BIA: Three new faces on the board

The BIA has added three new members to the Board of Directors. Calchan CEO Brenda Reynolds (pictured), Immunocore Chief Business Officer Eva-Lotta Allan and Polar Capital’s Partner – Healthcare Dan Mahony will join the board of the British BioIndustry Association from January 2017.
Read more

Ayoxxa: Bridging the gap

Cologne-based biotech Ayoxxa Biosystems GmbH announces that Rodney Turner has assumed duties as the interim CEO. Prior CEO Andreas Schmidt has stepped down.

Read more

Merus: Changes in management

Dutch immuno-oncology company Merus has appointed John Crowley its Chief Financial Officer. Former CFO Shelley Margetson has been elevated to Chief Operating Officer. 

Read more

TxCell: Cell engineering virtuoso

French cellular immunotherapy company TxCell has hired ex-Novartis Lab Head Li Zhou to lead its CAR-Treg programmes. Zhou was appointed Vice President Cell Engineering in October.

Read more

Targovax: CFO turned CEO

Norwegion immuno-oncology play Targovax has promoted Øystein Soug, previously the company’s Chief Financial Officer, to the role of Chief Executive Officer. He succeeds Gunnar Gårdemyr, who has stepped down.

Read more

Stora Enso: Consumer Board leader

Finnish-Swedish biomaterial expert Stora Enso has appointed Annica Bresky as Executive Vice President, Consumer Board division and member of the Group Leadership Team. Bresky joins from Iggesund Paperboard AB, part of the Swedish Holmen Group, where she held the position of President and CEO. 
Read more